We also extended the mouse model to 3xTg-AD mice, the results of CD4+ T cells immunofluorescence in line with our finding in APP/PS1 mice, but the difference was not as significant as APP/PS1 mouse group after PBMT treatment (Fig. 4C, D). The gene discussed is APP; the disease is Alzheimer disease.